ATLANTA—Results from the first large study of a vaccine for dengue fever — in 4000 Thai children — show that it is safe to use and effective — raising immunity to three out of the four “serotypes” of this mosquito-borne virus. Although these findings — announced at the American Society of Tropical Medicine and Hygiene annual meeting — show that complete protection — against all four virus types — is still not possible, Professor Jeremy Farrar of Oxford University’s Unit in Ho Chi Minh city told Peter Goodwin that expectations about the vaccine were perhaps too high, and that the results just announced are encouraging, because the risk of dengue is continually rising as more people travel around the world spreading the infection.
You may also like...
World Malaria Day 2012: Call for More Nets, New Insecticides 24 Apr, 2012 Rural to Urban Migration: Cardiovascular Health Risks Assessed in Lima, Peru 18 Apr, 2007 Plasmodium Ovale Malaria Parasite: Found To Be Two Species 14 Aug, 2010 London School of Hygiene & Tropical Medicine Audio News Review, August 25th, 2007 25 Aug, 2007
- Previous story New drug looks very promising in high risk chronic lymphocytic leukaemia
- Next story Acute promyelocytic leukaemia: arsenic better than chemotherapy to combine with retinoic acid?
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
- MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014